Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1224 Results

Title
Intervention Indication Therapeutic Area Year Actions
Ravulizumab (subcutaneous formulation) for treating paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome Ravulizumab (ALXN1210; Ultomiris) Atypical haemolytic uraemic syndrome (aHUS) , Paroxysmal nocturnal haemoglobinuria (PNH) Haematology , Nephrology 2022 View  |  Download
Ravulizumab for atypical haemolytic uraemic syndrome in adults and children – first line Ravulizumab (ALXN1210; Ultomiris) Atypical haemolytic uraemic syndrome (aHUS) Haematology , Nephrology 2018 View  |  Download
Ravulizumab for paroxysmal nocturnal haemoglobinuria in paediatrics Ravulizumab (ALXN1210; Ultomiris) Paroxysmal nocturnal haemoglobinuria (PNH) Haematology 2021 View  |  Download
Ravulizumab for treating generalised myasthenia gravis Ravulizumab (ALXN1210; Ultomiris) Myasthenia gravis (MG) Musculoskeletal System 2021 View  |  Download
Ravulizumab for treating thrombotic microangiopathies following haematopoietic stem cell transplantation in children Ravulizumab (ALXN1210; Ultomiris) Thrombotic microangiopathies Haematology 2023 View  |  Download
Ravulizumab for treatment of neuromyelitis optica spectrum disorder Ravulizumab (ALXN1210; Ultomiris) Neuromyelitis optica spectrum disorders Nephrology , Ophthalmology 2022 View  |  Download
RBX-2660 for the Treatment of Recurrent Clostridium Difficile Infection – third line RBX-2660 Clostridioides difficile infection Infectious Disease 2018 View  |  Download
Refanalin for Delayed Graft Function Following Kidney Transplant Refanalin (BB-3; ANG-3777) Delayed graft function (DGF) Nephrology 2018 View  |  Download
REGN5458 for relapsed or refractory multiple myeloma REGN5458 Multiple myeloma (MM) Haematological Cancer and Lymphomas 2022 View  |  Download
Relatlimab in combination with nivolumab for advanced melanoma – second line Nivolumab (Opdivo; BMS-936558; ONO-4538) , Relatlimab (BMS-986016; Anti-LAG-3) Melanoma Skin Cancer 2019 View  |  Download
1 2 89 90 91 92 93 122 123
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications